This inventor holds 1 USPTO granted patent. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2004.
Company Filing History:
Years Active: 2004
Title: The Innovations of Jacque Banville
Introduction
Jacque Banville is a notable inventor based in St. Hubert, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in the development of HIV integrase inhibitors. His work is crucial in the ongoing fight against HIV/AIDS.
Latest Patents
Jacque Banville holds 1 patent for his innovative work on HIV integrase inhibitors. His patent involves novel diketoacid compounds of Formula I, which are useful in the treatment of AIDS or AIDS-related complex (ARC). This invention represents a significant advancement in therapeutic options for patients.
Career Highlights
Banville is associated with Bristol-Myers Squibb Company, a leading global biopharmaceutical company. His role there has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry. His expertise in drug formulation and development has been instrumental in creating effective treatments.
Collaborations
Throughout his career, Jacque Banville has collaborated with esteemed colleagues, including Timothy D. Johnson and Michael A. Walker. These partnerships have fostered an environment of innovation and have led to the successful development of new therapeutic agents.
Conclusion
Jacque Banville's contributions to the field of HIV treatment through his innovative patents and collaborations highlight his importance as an inventor. His work continues to impact the lives of many individuals affected by HIV/AIDS.